Ad is loading...
HSTI
Price
$0.25
Change
-$0.00 (-0.00%)
Updated
Jul 16 closing price
INIS
Price
$0.03
Change
-$0.00 (-0.00%)
Updated
Nov 15 closing price
Ad is loading...

HSTI vs INIS

Header iconHSTI vs INIS Comparison
Open Charts HSTI vs INISBanner chart's image
High Sierra Technologies
Price$0.25
Change-$0.00 (-0.00%)
Volume$525
CapitalizationN/A
International Isotopes
Price$0.03
Change-$0.00 (-0.00%)
Volume$2.94K
CapitalizationN/A
HSTI vs INIS Comparison Chart
Loading...
View a ticker or compare two or three
VS
HSTI vs. INIS commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HSTI is a Hold and INIS is a Hold.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (HSTI: $0.25 vs. INIS: $0.03)
Brand notoriety: HSTI and INIS are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: HSTI: 100% vs. INIS: 3%
Market capitalization -- HSTI: $35.5M vs. INIS: $41.44M
HSTI [@Pharmaceuticals: Other] is valued at $35.5M. INIS’s [@Pharmaceuticals: Other] market capitalization is $41.44M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HSTI’s FA Score shows that 1 FA rating(s) are green whileINIS’s FA Score has 1 green FA rating(s).

  • HSTI’s FA Score: 1 green, 4 red.
  • INIS’s FA Score: 1 green, 4 red.
According to our system of comparison, both HSTI and INIS are a bad buy in the long-term.

Price Growth

HSTI (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while INIS (@Pharmaceuticals: Other) price change was -6.25% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -5.07%. For the same industry, the average monthly price growth was -7.87%, and the average quarterly price growth was -11.90%.

Reported Earning Dates

INIS is expected to report earnings on Nov 13, 2024.

Industries' Descriptions

@Pharmaceuticals: Other (-5.07% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

FUNDAMENTALS
Fundamentals
INIS($41.4M) has a higher market cap than HSTI($35.5M). INIS YTD gains are higher at: -25.000 vs. HSTI (-77.273). HSTI has higher annual earnings (EBITDA): -156.96K vs. INIS (-236.83K). INIS has more cash in the bank: 3.28M vs. HSTI (8.54K). HSTI has less debt than INIS: HSTI (518K) vs INIS (4M). INIS has higher revenues than HSTI: INIS (11.5M) vs HSTI (0).
HSTIINISHSTI / INIS
Capitalization35.5M41.4M86%
EBITDA-156.96K-236.83K66%
Gain YTD-77.273-25.000309%
P/E RatioN/A109.89-
Revenue011.5M-
Total Cash8.54K3.28M0%
Total Debt518K4M13%
FUNDAMENTALS RATINGS
HSTI vs INIS: Fundamental Ratings
HSTI
INIS
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
85
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10092
PRICE GROWTH RATING
1..100
8782
P/E GROWTH RATING
1..100
46
SEASONALITY SCORE
1..100
30n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

INIS's Valuation (85) in the null industry is in the same range as HSTI (91). This means that INIS’s stock grew similarly to HSTI’s over the last 12 months.

INIS's Profit vs Risk Rating (100) in the null industry is in the same range as HSTI (100). This means that INIS’s stock grew similarly to HSTI’s over the last 12 months.

INIS's SMR Rating (92) in the null industry is in the same range as HSTI (100). This means that INIS’s stock grew similarly to HSTI’s over the last 12 months.

INIS's Price Growth Rating (82) in the null industry is in the same range as HSTI (87). This means that INIS’s stock grew similarly to HSTI’s over the last 12 months.

HSTI's P/E Growth Rating (4) in the null industry is in the same range as INIS (6). This means that HSTI’s stock grew similarly to INIS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
VNQ93.800.05
+0.05%
Vanguard Real Estate ETF
IEUS54.810.01
+0.02%
iShares MSCI Europe Small-Cap ETF
JRE25.24N/A
N/A
Janus Henderson US Real Estate ETF
EFAX40.39-0.18
-0.44%
SPDR® MSCI EAFE Fssl Ful Free RsrvETF
IYC93.47-0.90
-0.95%
iShares US Consumer Discretionary ETF

HSTI and

Correlation & Price change

A.I.dvisor tells us that HSTI and INIS have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HSTI and INIS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HSTI
1D Price
Change %
HSTI100%
N/A
INIS - HSTI
9%
Poorly correlated
N/A
HYPMY - HSTI
5%
Poorly correlated
-5.72%
JUSHF - HSTI
4%
Poorly correlated
+14.10%
INDV - HSTI
2%
Poorly correlated
-3.25%
GTBIF - HSTI
2%
Poorly correlated
+3.42%
More